GlassScriptPhysician profile
Ryan P Frank
NPI 1528062130
$14,566.86
in general payments reported to CMS, 2019-2025
31 companies · $157 in 2025
The $157 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $382 · 2020: $60.90 · 2021: $314 · 2022: $13K · 2023: $550 · 2024: $460 · 2025: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,166.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $12,268.63 | 2022-2025 | Restrata Wound Matrix |
| Organogenesis INC. | $705.09 | 2019-2025 | Nushield, Puraply Wound Matrix, Puraply |
| Abbvie INC. | $277.83 | 2022-2025 | |
| Kerecis Limited | $254.91 | 2021-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Nevro Corp. | $139.58 | 2022-2024 | Senza |
| Melinta Therapeutics, LLC | $105.89 | 2019-2023 | Kimyrsa |
| Integra Lifesciences Corporation | $88.43 | 2019-2023 | Tenoglide |
| Convatec INC. | $67.39 | 2023-2024 | |
| Aroa Biosurgery Incorporated | $54.51 | 2019-2020 | |
| Avita Medical Americas, LLC | $51.86 | 2024 | |
| Paratek Pharmaceuticals, INC. | $48.63 | 2022-2025 | Nuzyra |
| Kowa Pharmaceuticals America, INC. | $48.17 | 2022-2023 | Seglentis |
| Polynovo North America LLC | $45.61 | 2022-2023 | |
| Surgenex LLC | $42.74 | 2025 | Renograft, Surmatrix, Ardeograft |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $39.30 | 2019-2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $38.38 | 2019 | |
| Wright Medical Technology, INC. | $31.48 | 2019-2020 | |
| Dynasplint Systems INC. | $29.77 | 2025 | Dynasplint |
| Medtronic, INC. | $25.80 | 2024 | Intellis Adaptivestim |
| Grt US Holding, INC. | $22.07 | 2022 | |
| Amgen INC. | $21.86 | 2024 | Krystexxa |
| Acumed LLC | $18.75 | 2023 | Osteomed, Acumed |
| Stryker Corporation | $18.14 | 2021 | |
| Zimmer Biomet Holdings, INC. | $17.90 | 2019 | |
| Smith+Nephew, INC. | $16.66 | 2022 | |
| Biotissue Holdings INC. | $16.15 | 2023 | |
| Nabriva Therapeutics, Plc | $16.12 | 2022 | |
| Hartmann USA, INC. | $15.43 | 2021 | |
| Baudax Bio INC. | $15.39 | 2021 | |
| Bioventus LLC | $12.39 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $12.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Frank listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.